GILD:NGS-Gilead Sciences Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 76.77

Change

0.00 (0.00)%

Market Cap

USD 98.10B

Volume

6.32M

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-04 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 257.50B
AMGN Amgen Inc

N/A

USD 172.25B
SNY Sanofi ADR

N/A

USD 141.45B
BIIB Biogen Inc

N/A

USD 29.85B
GRFS Grifols SA ADR

N/A

USD 6.95B
AMRN Amarin Corporation PLC

N/A

USD 0.25B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing GILD

BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

N/A

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.31 % 0.75 %

N/A

CAD 0.07B
FHI-B:CA CI Health Care Giants Cov.. 5.31 % 0.00 %

N/A

CAD 0.05B
HDLB ETRACS Monthly Pay 2xLeve.. 5.14 % 0.00 %

N/A

USD 0.01B
XDNA:CA iShares Genomics Immunolo.. 4.62 % 0.00 %

N/A

CAD 4.99M
UDI USCF ETF Trust 4.00 % 0.00 %

N/A

N/A
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.45M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.08B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.71M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.96B
TBG EA Series Trust 3.83 % 0.00 %

N/A

USD 0.06B
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

N/A

N/A
MDLV 3.19 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 2.99 % 0.00 %

N/A

USD 0.04B
MHOT:AU VanEck Morningstar Wide M.. 2.71 % 0.00 %

N/A

N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.69 % 0.00 %

N/A

USD 0.04B
MOAT:AU VanEck Morningstar Wide M.. 2.66 % 0.00 %

N/A

USD 0.93B
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

N/A

N/A
XDGI:XETRA Xtrackers MSCI Global SDG.. 2.23 % 0.00 %

N/A

USD 0.02B
SDOG ALPS Sector Dividend Dogs.. 2.17 % 0.40 %

N/A

USD 1.23B
GOAT:AU VanEck Morningstar World .. 2.13 % 0.00 %

N/A

USD 0.04B
SAGP The Advisorsa Inner Circl.. 2.09 % 0.00 %

N/A

USD 0.04B
DHS:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 1.91 % 1.14 %

N/A

USD 1.01B
RSPH Invesco S&P 500® Equal.. 1.81 % 0.00 %

N/A

USD 1.02B
HEAL:SW iShares Healthcare Innova.. 1.71 % 0.00 %

N/A

N/A
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

N/A

N/A
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.45B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

N/A

USD 3.31M
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

N/A

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 7.71B
IBCD 0.00 % 0.10 %

N/A

N/A
MOAT 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
JIGB 0.00 % 0.14 %

N/A

N/A
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

N/A

USD 1.64B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

N/A

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

N/A
XSFD:LSE Xtrackers S&P Select Fron.. 0.00 % 0.00 %

N/A

USD 0.09B
XSFR:LSE Xtrackers S&P Select Fron.. 0.00 % 0.00 %

N/A

USD 0.09B
JPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 4.59M
UBBB:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.15B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 1.83M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.14B
DX2Z:XETRA Xtrackers - S&P Select Fr.. 0.00 % 0.00 %

N/A

USD 0.10B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.05B
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

USD 1.13B
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 7.81M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 7.81M
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

N/A

USD 0.04B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

N/A

USD 0.02B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.23% 50% F 44% F
Dividend Return 1.90% 75% C 54% F
Total Return -3.33% 60% D- 45% F
Trailing 12 Months  
Capital Gain -2.43% 70% C- 49% F
Dividend Return 1.96% 25% F 33% F
Total Return -0.47% 70% C- 49% F
Trailing 5 Years  
Capital Gain 19.99% 57% F 63% D
Dividend Return 19.97% 60% D- 78% C+
Total Return 39.97% 57% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 2.28% 80% B- 50% F
Dividend Return 6.06% 80% B- 58% F
Total Return 3.78% 80% B- 75% C
Risk Return Profile  
Volatility (Standard Deviation) 17.75% 60% D- 79% B-
Risk Adjusted Return 34.13% 70% C- 66% D+
Market Capitalization 98.10B 63% D 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.00 14% 6%
Price/Book Ratio 3.72 38% 28%
Price / Cash Flow Ratio 12.15 88% 24%
Price/Free Cash Flow Ratio 9.78 75% 30%
Management Effectiveness  
Return on Equity 2.39% 38% 62%
Return on Invested Capital 18.80% 100% 87%
Return on Assets 10.50% 100% 95%
Debt to Equity Ratio 101.93% 50% 22%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.